Unidoc Health closes $1.5-million offering

Executive Summary

• Unidoc Health Corp. has closed its fully subscribed non-brokered private placement under the Listed Issuer Financing Exemption (LIFE).
• The company issued 10 million units at a price of $0.15 per unit, raising aggregate gross proceeds of $1.5 million.
• Proceeds are designated for inventory, marketing, investor relations, working capital, and general corporate purposes.

Key Details

• Transaction Structure: Non-brokered private placement closed under the Listed Issuer Financing Exemption (LIFE).
• Units Issued: 10,000,000 units.
• Price Per Unit: $0.15 CAD.
• Gross Proceeds: $1,500,000 CAD.
• Warrant Terms: Each unit includes one transferable common share purchase warrant.
  • Exercise Price: $0.25 per common share.
  • Expiration Date: October 27, 2028.
• Use of Proceeds: Inventory, marketing, investor relations services, working capital, and general corporate purposes.
• Finder's Fee: $31,374.75 paid to an eligible arm's-length finder.
• Regulatory Status: Issued pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 in British Columbia; securities are not subject to resale restrictions for Canadian resident subscribers.

Notable Quotes

• None provided in the text.